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Background: Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide. Patients with
COPD frequently have systemic comorbidities that often require unscheduled hospitalization for exacerbation and
deterioration of physical conditions, and can have a poor prognosis. We verified factors affecting patients’ short-term
mortality, using a national inpatient database in Japan.
Methods: We retrospectively collected data for COPD patients (age: >40 years) with emergency admission between
July 2010 and March 2013, using the Diagnosis Procedure Combination database. We performed multivariate logistic
analyses fitted with a generalized estimating equation to assess factors associated with all-cause in-hospital mortality.
Results: A total of 177,207 patients (mean age: 77.5 years; males: 72.9%) were identified. All-cause in-hospital
death occurred in 23,614 patients (13.7%). Higher mortality was associated with older age, male sex, lower body
mass index, more severe dyspnea, lower level of consciousness, and worse activities of daily life. Higher mortality
was also associated with comorbid conditions, including bacterial pneumonia, aspiration pneumonia, interstitial
pneumonitis, pulmonary embolism, respiratory failure, lung cancer, heart failure, cerebral infarction, liver cirrhosis,
and chronic renal failure.
Conclusions: Our study demonstrated that all-cause in-hospital mortality in patients with COPD who required
emergency hospitalization was associated with deteriorated general conditions and comorbidities at admission.
Physicians should take into account these prognostic factors to choose better treatment options for COPD
patients.
Keywords: Chronic obstructive pulmonary disease, All-cause in-hospital mortality, Activities of daily life, Emergency
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Chronic obstructive pulmonary disease (COPD) is a major
cause of chronic morbidity and mortality throughout the
world, and the fourth cause of death worldwide [1,2].
COPD is characterized by persistent airflow limitation and
is usually progressive [3]. The characteristic symptoms of
COPD are cough, productive sputum, and dyspnea on ex-
ertion, which lead to poor activities of daily life (ADL) and* Correspondence: YAMAUCHIY-INT@h.u-tokyo.ac.jp
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article, unless otherwise stated.decreased health-related quality of life. Patients with
COPD often require emergency hospital admission be-
cause of acute exacerbations of COPD, respiratory failure,
and deterioration of general conditions, which would
threaten their lives [4].
Moreover, COPD often coexists with other systemic co-
morbid diseases, such as lung cancer, cardiovascular
disease, osteoporosis, and diabetes mellitus [5]. These co-
morbidities have shared risk factors with COPD, and can
be considered to influence one another. The comorbidities
in COPD would also become exacerbated, require emer-
gency hospitalization of the patients, and affect their
mortality [6].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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patients with COPD, including acute exacerbations of
COPD and their comorbid diseases, is important and
could lead to a better prognosis for the patients through
the induction of appropriate interventions. However, there
are few available data regarding all-cause mortality in
these patients, although there are several studies on the
mortality of patients with acute exacerbations of COPD
[7,8].
In this study, we aimed to evaluate the short-term all-
cause in-hospital mortality of patients with COPD who
required emergency hospital admission not only for exac-
erbations of COPD, but also for any cause. We tried to
verify factors, including patients’ general conditions and
comorbidities at admission, that affect the mortality after
emergency admission. The obtained results suggest the
importance of understanding the patients’ general condi-
tions and comorbidities at admission.
Methods
Diagnosis Procedure Combination (DPC) database
The DPC database is a nationwide administrative in-
patient database in Japan, and includes administrative
claims data and discharge abstract data. The main diagno-
sis, comorbidities present at admission, and complications
occurring during hospitalization are coded using Inter-
national Classification of Disease and Related Health
Problems 10th Revision (ICD-10) codes accompanied by
text data in Japanese. The database also contains the fol-
lowing patient details: age; sex; body height and weight;
severity of dyspnea based on the Hugh-Jones Dyspnea
Grade [9] at admission; levels of consciousness based on
the Japan Coma Scale [10,11] at admission and discharge;
status of disability of ADL based on the Barthel Index
[12,13] at admission; and discharge status, including in-
hospital death.
Grading of dyspnea severity based on the Hugh-Jones
classification [9] was defined as follows: I, patient’s breath-
ing is as good as that of other people of their own age and
build during work, walking, and climbing hills or stairs; II,
patient is able to walk at pace with normal people of their
own age and build on level ground, but is unable to keep
up on hills or stairs; III, patient is unable to keep up with
normal people on level ground, but is able to walk about a
mile or more at their own speed; IV, patient is unable to
walk more than about 50 yards on level ground without a
rest; V, patient is breathless on talking or undressing, or
unable to leave their house because of breathlessness; Un-
specified, patient is unable to be classified into the above
grades because of bedridden status. The level of con-
sciousness on the Japan Coma Scale [10,11] was defined
as follows: one-digit codes (1–3) are attributed to patients
who are awake without any stimuli; two-digit codes (10–
30) are attributed to patients who can be aroused by somestimuli; three-digit codes (100–300) are attributed to those
with coma. The Japan Coma Scale and Glasgow Coma
Scale assessments are well correlated [14].
This study was approved by the Institutional Review
Board of The University of Tokyo, which waived the re-
quirement for patient informed consent because of the
anonymous nature of the data.
Patient selection
We retrospectively collected data for patients aged over
40 years who had been admitted to hospital because of
COPD (ICD-10 codes: J41, J42, J43, J44) as the main dis-
ease, or who had been admitted for any cause, but had
COPD as a comorbidity, required emergency hospital ad-
mission, and were discharged between 1 July 2010 and 31
March 2013.
Comorbidities
The following comorbidities were identified using ICD-
10 codes: pneumonia caused by pathogenic microbes
(J10–J18); aspiration pneumonia (J690); interstitial pneu-
monia (J84); pulmonary embolism (I26); respiratory fail-
ure (J96); lung cancer (C34); heart failure (I50); bone
fracture (S02, S12, S22, S32, S42, S52, S62, S72, S82,
S92, T02, T10, T12); cerebrovascular diseases (I60–I69);
liver cirrhosis (K703, K74); chronic renal failure (N18).
Outcome
The outcome of this study was all-cause in-hospital mor-
tality in patients with COPD who required emergency
hospital admission.
Statistical analysis
The chi-square test was used to compare in-hospital mor-
tality between the groups. A multivariate logistic regres-
sion for in-hospital mortality was performed to analyze
patient-level factors associated with the outcome after ad-
justment for within-hospital clustering using a generalized
estimating equation [15]. The threshold for significance
was a value of P < 0.05. All statistical analyses were per-
formed using SPSS version XX (IBM, Somers, NY).
Results
Patient characteristics
Among 19 million patients recorded during the 33 months
between July 2010 and March 2013, we identified 172,707
patients with COPD who were aged over 40 years
and required emergency hospital admission to DPC-
participating hospitals. Among them, the number of pa-
tients admitted primarily because of COPD was 18,487,
and the number of patients admitted because of other
causes, but with COPD as a comorbidity, was 154,220.
The mean age was 77.5 (standard deviation (SD) 9.8)
years in total, 77.2 (SD 9.4) years for males, and 78.5
Table 1 All-cause in-hospital mortality in patients with









40–49 2,055 71 3.5
50–59 6,241 418 6.7
60–69 25,359 2,241 8.8
70–79 57,127 7,137 12.5
80–89 68,092 11,144 16.4
90–99 13,511 2,541 18.8
>100 322 62 19.3
Sex <0.001
Male 136,632 19,858 14.5
Female 36,075 3,756 10.4
BMI <0.001
<18.5 55,376 9,399 17
18.5–22.9 61,183 6,310 10.3
23.0–24.9 16,190 1,275 7.9
25.0–29.9 12,970 920 7.1
>30.0 2,184 148 6.8
Dyspnea grade <0.001
I 9,361 299 3.2
II 13,656 524 3.8
III 14,625 793 5.4
IV 28,156 2,185 7.8
V 34,890 7,873 22.6
Unspecified 17,702 5,011 28.3
Consciousness level <0.001
Alert 141,110 15,125 10.7
Dull 19,303 3,841 19.9
Somnolence 4,763 1,450 30.4
Coma 4,370 2,344 53.6
ADL score by Barthel
Index
<0.001
100 45,488 2,534 5.6
75–95 15,729 1,051 6.7
50–70 22,034 2,144 9.7
25–45 14,822 2,021 13.6
0–20 43,791 11,249 25.7
Pneumonia caused by microbes 53,204 9,432 15.1 <0.001
Aspiration pneumonia 12,650 4,286 25.3 <0.001
Interstitial pneumonitis 8,791 2,862 24.6 <0.001
Pulmonary embolism 1,050 216 17.1 <0.001
Respiratory failure 51,532 11,093 17.7 <0.001
Lung cancer 13,930 4,448 24.2 <0.001
Heart failure 32,748 9,276 16.1 <0.001
Table 1 All-cause in-hospital mortality in patients with
COPD who required emergency hospitalization
(Continued)
Cerebrovascular diseases 7,504 1,394 15.7 <0.001
Liver cirrhosis 1,028 232 18.4 <0.001
Chronic renal failure 4,343 965 18.2 <0.001
Abbreviations: BMI Body mass index, ADL Activities of daily life.
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(BMI) was 20.1 (SD 3.9) in total, 20.1 (SD 3.8) for
males, and 20.1 (SD 4.6) for females. The median
length of hospital stay was 16 (interquartile range
(IQR) 10–29) days.
All-cause in-hospital mortality in patients with COPD who
required emergency hospital admission
Overall, 23,614 patients (13.7%) died in hospital after
emergency hospital admission. The median time from ad-
mission to death was 19 (IQR 6–42) days. Table 1 shows
the relationships between in-hospital mortality and pa-
tients’ general conditions and comorbidities. All-cause in-
hospital mortality in patients with COPD was associated
with older age, male sex, lower BMI, more severe dyspnea
by the Hugh-Jones Dyspnea Grade, lower level of con-
sciousness by the Japan Coma Scale, and worse disabil-
ity of ADL by the Barthel Index. In addition, higher
mortality in patients with COPD was associated with
comorbid diseases, including bacterial or viral pneu-
monia, aspiration pneumonia, interstitial pneumonitis,
pulmonary embolism, respiratory failure, lung cancer,
heart failure, cerebrovascular diseases, liver cirrhosis,
and chronic renal failure.
Adjusted risk factors for in-hospital mortality in patients
with COPD
Table 2 shows the results of the logistic regression ana-
lyses for all-cause in-hospital mortality. Higher mortality
in the COPD patients was associated with older age, male
sex, lower BMI, more severe dyspnea, lower level of con-
sciousness, and worse disability of ADL. In addition,
higher morality was associated with comorbid diseases at
admission, including bacterial or viral pneumonia, respira-
tory failure, aspiration pneumonia, interstitial pneumonitis,
pulmonary embolism, lung cancer, heart failure, cerebro-
vascular diseases, liver cirrhosis, and chronic renal failure.
Discussion
Our study using a national inpatient database in Japan in-
vestigated all-cause in-hospital mortality in 172,707 pa-
tients with COPD who required emergency hospital
admission. The all-cause in-hospital mortality was 13.7%.
Older age, male sex, lower BMI, more severe dyspnea,
lower level of consciousness, and worse disability of ADL
Table 2 Adjusted odds ratios of all-cause in-hospital






Age (yr) 40–49 Reference
50–59 1.64 1.07–2.50 0.022
60–69 1.70 1.14–2.54 0.009
70–79 2.15 1.45–3.19 <0.001
80–89 2.53 1.70–3.75 <0.001
90–99 2.67 1.79–3.98 <0.001
>100 2.50 1.37–4.58 0.003
Sex Male Reference
Female 0.63 0.59–0.68 <0.001
BMI <18.5 1.56 1.48–1.65 <0.001
18.5–22.9 Reference
23.0–24.9 0.73 0.67–0.81 <0.001
25.0–29.9 0.76 0.68–0.84 <0.001
>30.0 0.69 0.52–0.92 <0.001
Dyspnea grade I Reference
II 1.25 1.03–1.53 0.027
III 1.50 1.23–1.82 <0.001
IV 2.02 1.69–2.41 <0.001
V 5.36 4.47–6.42 <0.001
Unspecified 5.77 4.76–6.99 <0.001
Consciousness level Alert Reference
Dull 1.30 1.20–1.40 <0.001
Somnolence 1.64 1.46–1.84 <0.001




75–95 1.07 0.96–1.19 0.251
50–70 1.38 1.25–1.51 <0.001
25–45 1.94 1.76–2.15 <0.001
0–20 3.06 2.78–3.37 <0.001
Pneumonia caused
by microbes












Yes 1.53 1.15–2.04 0.004
No Reference
Table 2 Adjusted odds ratios of all-cause in-hospital
mortality in patients with COPD who required emergency
hospitalization (Continued)
Respiratory failure Yes 1.32 1.24–1.47 <0.001
No Reference
Lung cancer Yes 4.14 3.79–4.51 <0.001
No Reference




Yes 1.17 1.01–1.34 0.032
No Reference
Liver cirrhosis Yes 1.99 1.48–2.67 <0.001
No Reference
Chronic renal failure Yes 1.75 1.52–2.01 <0.001
No Reference
Abbreviations: BMI Body mass index, ADL Activities of daily life.
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tality in these patients. In addition, comorbid diseases at
emergency admission, including bacterial or viral pneumo-
nia, aspiration pneumonia, interstitial pneumonitis, pul-
monary embolism, respiratory failure, lung cancer, heart
failure, cerebral infarction, liver cirrhosis, and chronic renal
failure, were associated with higher mortality.
The present study has demonstrated that higher mor-
tality in patients with COPD who required emergency
hospitalization was significantly associated with patients’
general conditions at emergency admission. Previous
studies reporting the mortality of patients with acute ex-
acerbation of COPD demonstrated that higher mortality
in those patients was associated with older age [8,16,17],
male sex [17,18], lower BMI [7,19], severe dyspnea
[19,20], and lower level of consciousness [17,21,22]. In
the present study, these factors were also predictors of
mortality in patients with not only exacerbations of
COPD but also all-cause emergency hospital admission.
Our study further demonstrated that disability of ADL
scored by the Barthel Index was an important predictor of
short-term in-hospital mortality in emergently hospital-
ized patients with COPD. The Barthel Index has been
used as an index for disability of ADL and evaluations,
and is known to be one of the risk factors for early un-
planned readmission in older patients [23]. The Barthel
Index was also reported to be impaired in older patients
with COPD [24] and associated with 6-month mortality in
older patients with mild COPD [25]. However, there are
no reports about the relationship between short-term
mortality in emergently hospitalized patients with COPD
and the Barthel Index at admission. A previous study by
Garcia-Aymerich et al. [26] demonstrated that regular
physical activity reduced hospitalization and mortality in
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COPD should be encouraged to maintain or increase their
level of regular physical activities, and suggested the im-
portance of physical activities in patients with COPD. Re-
cently, Waschki et al. [27] reported that daily physical
activities were a strong predictor of long-term all-cause
mortality in patients with COPD, using physical activity
levels measured with a multisensory armband. Thus,
physical activities in COPD patients should be an import-
ant factor affecting both their long-term and short-term
mortality.
Comorbid diseases with COPD, including pulmonary
and extrapulmonary comorbidities, were also reported to
be important for the mortality of patients with COPD
[5,28]. In terms of pulmonary comorbidities, previous
studies reported that pneumonic exacerbation of COPD
[29], lung cancer [30], and pulmonary embolism [31] were
associated with increased mortality in patients with
COPD. Our study also demonstrated that these prognostic
factors were predictors of mortality in patients with
COPD who required emergency admission. In particular,
the mortalities for aspiration pneumonia, interstitial pneu-
monitis, and lung cancer were higher than those of other
comorbidities. The coexistence of COPD and pulmonary
comorbidities would functionally and pathophysiologically
influence one another and might affect the higher mortal-
ity. In terms of extrapulmonary comorbidities, heart fail-
ure, cerebrovascular diseases, liver diseases, and renal
diseases were reported to be independent predictors of
mortality in patients with acute exacerbation of COPD
[7,32]. Our study also demonstrated that these comorbidi-
ties were predictors of mortality in patients with COPD
who required emergency admission, and confirmed the
findings of the previous studies.
Several limitations in this study should be acknowl-
edged. The diagnoses of COPD and other comorbidities
were based on physician-diagnosed COPD and comorbid-
ities. The accuracy of the diagnosis of COPD was not cer-
tified by specialist-diagnosed COPD. However, since
COPD is not always diagnosed by specialists in the real-
world, the data for physician-diagnosed COPD for studies
such as epidemiologic studies and the present study are
thought to be meaningful results. In addition, since the
DPC database does not include the stages of COPD sever-
ity or details of pulmonary function tests, including forced
expiratory volume in 1 second and other indices, the de-
gree of airflow limitation was not evaluated in this study.
Thus, we cannot discuss the association between mortality
of patients with COPD and severity of COPD by airflow
limitation. Although airflow limitation is known to be one
of the important predictors of mortality, the patients’ gen-
eral conditions and comorbidities at admission were also
independent predictors for emergently hospitalized pa-
tients with COPD, independently of the severity of COPD[27]. Moreover, it was recently reported that a former-year
exacerbation is a significant predictor of COPD exacerba-
tion [33]. However, evaluation of former-year exacerba-
tions was too difficult in the present study, because
patients are not always admitted to the same hospital and
it is impossible to identify individuals readmitted to other
hospitals in the nationwide DPC database. Therefore, we
could not evaluate the former-year exacerbations in this
study or discuss the association with mortality.
Conclusions
In conclusion, our present study investigated all-cause
in-hospital mortality in patients with COPD who re-
quired emergency hospital admission not only for exac-
erbations of COPD, but also for any cause. Higher
mortality was associated with older age, male sex, lower
BMI, more severe dyspnea, lower level of consciousness,
and worse disability of ADL on admission. Comorbidi-
ties with pneumonia, including aspiration and interstitial
pneumonitis, pulmonary embolism, respiratory failure,
lung cancer, heart failure, cerebrovascular disease, liver
cirrhosis, and chronic renal failure were associated with
higher mortality. Therefore, recognition of patients’ gen-
eral conditions and their comorbidities at admission
would be helpful for understanding the all-cause mortal-
ity and would provide a strategic direction for choosing
better treatment options for COPD patients.
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